Local
Vaso Corporation Announces Financial Results for Third Quarter of 2026
Meet in Common connects news with real conversations. Use ThinkMatch to arrange a Roundtable and meet people to discuss this story.
Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.
Source: The Manila Times

PLAINVIEW, N.Y., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso”) (OTCQX: VASO), a leading MedTech company with a business portfolio in professional sales services and proprietary non-invasive medical products, today announced its operating results for the three months ended September 30, 2026. "For the third quarter of 2026, the Company recorded net income of $568 thousand on total revenue of $10.8 million, as compared to net income of $1.7 million on total revenue of $11.4 million for the same quarter of the prior year, with healthcare IT and network services businesses excluded from both periods, as we divested the two businesses in November 2025 and July 2026, respectively,” commented Dr. Jun Ma, President and Chief Executive Officer of Vaso Corporation.
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at The Manila Times



